No recent analyst price targets found for NCNA.
Latest News for NCNA
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
NUC-7738 Demonstrates Clinical Activity and Favorable Safety in Patients with PD-1 Inhibitor-Resistant Melanoma
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NCNA.
U.S. House Trading
No House trades found for NCNA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.